Jonathan Basil Fitzgerald

This inventor holds 19 USPTO granted patents and 31 published patent applications, plus 2 CIPO patents and 7 EPO patents, primarily in Cancer Treatment. Top assignees: Ipsen Biopharm Limited, Merrimack Pharmaceuticals, Inc., Ispen Biopharm Ltd.. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jonathan Basil Fitzgerald. Retrieved from https://idiyas.com/inventor/jonathan-basil-fitzgerald

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 19 (Patent Applications = 31)

% Patents Active = 84.2

CIPO Patents = 2 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 12)

Average Co-Inventor Count = 5.8

ph-index = 8

Forward Citations = 129(Granted Patents)

Location History:

Cambridge, MA (US) (2016)
Arlington, MA (US) (2013 - 2023)

Company Filing History:

9 out of 46

Ipsen Biopharm Limited

patents

9 out of 54

Merrimack Pharmaceuticals, Inc.

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

Pancreatic Cancer

Combination Therapy

Liposomal Irinotecan

Oxaliplatin

Monospecific Antibodies

Bispecific Antibodies

Metastatic Cancer

Small Cell Lung Cancer

Gastric Cancer

5-Fluorouracil

Therapeutic Response Prediction

Anti-IGF-1R

19 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12364691 - Methods for treating pancreatic cancer using combination therapies (2025-07-22),

2. 11844795 - Combination therapy for cancer treatment (2023-12-19),

3. 11369597 - Methods for treating pancreatic cancer using combination therapies (2022-06-28),

4. 11344552 - Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin (2022-05-31),

5. 11318131 - Nanoliposomal irinotecan for use in treating small cell lung cancer (2022-05-03),

6. 11071726 - Treating gastric cancer using combination therapies comprising liposomal irinotecan, oxaliplatin, 5-fluorouracil (and leucovorin) (2021-07-27),

7. 10980795 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan (2021-04-20),

8. 10478428 - Combination therapy for cancer treatment (2019-11-19),

9. 9938346 - Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies (2018-04-10),

10. 9895365 - Combination therapy for cancer treatment (2018-02-20),

11. 9717724 - Methods for treating pancreatic cancer using combination therapies (2017-08-01),

12. 9556274 - Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies (2017-01-31),

13. 9527914 - Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies (2016-12-27),

14. 9492442 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan (2016-11-15),

15. 9452162 - Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan (2016-09-27),

Title: Jonathan Basil Fitzgerald: Pioneering Inventor from Arlington, MA

Introduction: Jonathan Basil Fitzgerald is a distinguished inventor hailing from Arlington, MA, known for his groundbreaking contributions to various fields of technology and innovation.

Latest Patents: Jonathan Basil Fitzgerald holds several patents in the areas of renewable energy, artificial intelligence, and sustainable agriculture, showcasing his versatility and forward-thinking approach to invention.

Career Highlights: With a career spanning over two decades, Jonathan Basil Fitzgerald has worked with renowned research institutions and leading tech companies, consistently pushing the boundaries of what is possible through his innovative solutions.

Collaborations: Throughout his career, Jonathan Basil Fitzgerald has collaborated with top universities and forward-looking companies, fostering a culture of innovation and knowledge-sharing that has led to remarkable advancements in the industry.

Conclusion: Jonathan Basil Fitzgerald's passion for innovation and his relentless drive to create a better future through his inventions make him a true pioneer in the world of technology. His work continues to inspire and shape the landscape of innovation for generations to come.

Profile summary based on public USPTO records.